Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL
Titel:
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL
Auteur:
Graff, J.N. Baciarello, G. Armstrong, A.J. Higano, C.S. Iversen, P. Flaig, T.W. Forer, D. Parli, T. Phung, D. Tombal, B. Beer, T.M. Sternberg, C.N.